Literature DB >> 8480193

The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group.

C M Kessler1, C A Ludlam.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8480193

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  4 in total

1.  Acquired haemophilia A after stem cell transplant for sickle cell disease: treatment with recombinant porcine factor VIII (OBI-1) and tolerance induction with rituximab/prednisone.

Authors:  J N Lozier; K Nghiem; M Lee; B Hodsdon; G Joe; R P Weitzel; J F Tisdale; M Hsieh
Journal:  Haemophilia       Date:  2014-03       Impact factor: 4.287

2.  Acquired hemophilia successfully treated with oral immunosuppressive therapy.

Authors:  J J Lee; I J Chung; M R Park; D H Yang; S H Cho; D W Ryang; H J Kim
Journal:  Korean J Intern Med       Date:  2000-07       Impact factor: 2.884

3.  A global quantitative survey of hemostatic assessment in postpartum hemorrhage and experience with associated bleeding disorders.

Authors:  Andra H James; David L Cooper; Michael J Paidas
Journal:  Int J Womens Health       Date:  2017-07-03

4.  Hemostatic assessment, treatment strategies, and hematology consultation in massive postpartum hemorrhage: results of a quantitative survey of obstetrician-gynecologists.

Authors:  Andra H James; David L Cooper; Michael J Paidas
Journal:  Int J Womens Health       Date:  2015-11-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.